GLENMARK - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 2.3
Show all parameters (20 more)
🧾 Trade Setup
Optimal entry point would be 2,375 ₹ – a stop-loss order just below the current price. Target level one is 2,450 ₹, utilizing the breakout momentum. An exit strategy should be in place at 2,425 ₹ to protect profits or implement a trailing stop loss to manage risk given the high valuation. Overall verdict: cautiously bullish for immediate gains but monitor closely.
✅ Positive
The stock is experiencing a significant surge in volume – nearly double the average weekly volume. Price action shows a strong bullish trend with a solid breakout above the 50 DMA and a sustained push towards the recent high of 2,538 ₹.
⚠️ Limitation
Despite the impressive volume, the elevated P/E ratio of 46.0 compared to the industry PE of 34.8 suggests overvaluation. Furthermore, while the recent launch of GLIPIQ® is positive, it’s a relatively small event and could be quickly priced in; continued momentum relies on sustaining this breakout.
🏭 Industry
The pharmaceutical sector is currently driven by innovation and drug launches, with Glenmark benefiting from the introduction of GLIPIQ®. However, investor sentiment remains sensitive to regulatory changes and patent expirations, which could trigger volatility.